In patients with malignancies, thrombocytosis has previously been related to disease stage,
histological type, and survival. In the present study, the prevalence of thrombocytosis and …

Background: Thrombocytosis can accompany various cancers including lung cancer. This
finding has recently been suggested to indicate poor prognosis. Objectives and Methods …

Background: Solid tumours have worse prognosis when associated with thrombocytosis.
Our study assessed the prognostic value of thrombocytosis, and its relation with smoking …

Relationship between thrombocytosis and poor prognosis has been reported in lung cancer.
However, the majority of previous studies included many advanced stage and small cell …

Thrombocytosis and coagulation systems activation are commonly associated with disease
progression and are suggested poor prognostic factors in patients with malignancies. This …

The objective of this study was to evaluate the clinical value of an elevated platelet count
and other routine laboratory tests for predicting malignancy in patients with radiologically …

Background Thrombocytosis is commonly associated with malignant disease and has
recently been suggested to be a poor prognostic indicator in patients with lung cancer and …

Platelet counts were evaluated in 714 patients with advanced non-small cell lung cancer (N-
SCLC), small cell carcinoma of the lung (SCCL), and colon cancer entered to a clinical trial …

Thrombocytosis is an adverse prognostic factor in many types of cancer. These include
breast cancer, ovarian and other gynecologic cancers, renal cell carcinoma and lung …

BACKGROUND: Thrombocytosis in patients with cancer has been reported to be associated
with increased expression of angiogenic factors and with a poor prognosis in some types of …